Public Employees Retirement System of Ohio Purchases 2,566 Shares of Astera Labs, Inc. $ALAB

Public Employees Retirement System of Ohio increased its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 4.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 67,056 shares of the company’s stock after purchasing an additional 2,566 shares during the period. Public Employees Retirement System of Ohio’s holdings in Astera Labs were worth $7,349,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the company. Reflection Asset Management purchased a new stake in Astera Labs in the 4th quarter worth about $25,000. Smartleaf Asset Management LLC lifted its stake in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in shares of Astera Labs during the fourth quarter valued at approximately $33,000. Whipplewood Advisors LLC boosted its position in shares of Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after buying an additional 319 shares during the period. Finally, Assetmark Inc. grew its stake in shares of Astera Labs by 78.9% during the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after buying an additional 101 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Insider Activity

In related news, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 139,951 shares of the stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the transaction, the chief executive officer owned 3,929,183 shares in the company, valued at approximately $786,465,269.28. The trade was a 3.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 1,676,845 shares of company stock worth $444,928,806. Company insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Susquehanna increased their price target on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Stifel Nicolaus boosted their price objective on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. UBS Group upped their price objective on Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a research report on Monday, June 29th. Needham & Company LLC increased their target price on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Finally, Royal Bank Of Canada lifted their target price on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $282.00.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $260.23 on Wednesday. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The firm has a market capitalization of $44.61 billion, a price-to-earnings ratio of 175.83, a PEG ratio of 3.27 and a beta of 3.66. The stock has a 50 day moving average price of $360.60 and a 200 day moving average price of $227.59.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same period last year, the business posted $0.33 EPS. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Analysts forecast that Astera Labs, Inc. will post 1.86 earnings per share for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.